Stock Yards Bancorp (SYBT) director reports 60-share award and large holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Schutte John reported acquisition or exercise transactions in this Form 4 filing.
Stock Yards Bancorp director John Schutte reported an award of 60 shares of common stock on February 25, 2026 at $66.78 per share. These shares are held indirectly through a Trust Director Deferred Compensation Plan, bringing that indirect position to 8,890 shares. He also reports direct holdings of 1,000 stock appreciation rights and 83,768 shares of common stock as of the same date.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Schutte John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 60 | $66.78 | $4K |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 8,890 shares (Indirect, Trust Director Deferred Comp Plan);
Stock Appreciation Right — 1,000 shares (Direct);
Common Stock — 83,768 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Stock Yards Bancorp (SYBT) report for John Schutte?
Stock Yards Bancorp director John Schutte reported an award of 60 shares of common stock. The award was recorded on February 25, 2026 and is classified as a grant or other acquisition, not an open-market purchase or sale.
What direct equity and derivative positions does John Schutte report in SYBT?
John Schutte reports direct holdings of 83,768 shares of Stock Yards Bancorp common stock. He also reports a direct position in 1,000 stock appreciation rights, which are derivative instruments that reference the company’s common stock rather than being ordinary shares themselves.
Does the John Schutte Form 4 for SYBT show any stock sales?
The Form 4 for John Schutte does not report any stock sales. It records an award of 60 common shares as a grant or other acquisition and lists existing holdings in common stock and stock appreciation rights without disclosing sale transactions.